(22R,23R)-2A,3A,22,23-TETRAHYDROXY-24-ETHYL-BETA-HOMO-7-OXA-5A-CHOLESTAN-6-ONE - Names and Identifiers
Name | (22R,23R)-2A,3A,22,23-TETRAHYDROXY-24-ETHYL-BETA-HOMO-7-OXA-5A-CHOLESTAN-6-ONE
|
Synonyms | 28- high brassinolide (22R,23R)-2A,3A,22,23-TETRAHYDROXY-24-ETHYL-BETA-HOMO-7-OXA-5A-CHOLESTAN-6-ONE 6H-Benz[c]indeno[5,4-e]oxepin-6-one, 1-[(1S,2R,3R,4S)-4-ethyl-2,3-dihydroxy-1,5-dimethylhexyl]hexadecahydro-8,9-dihydroxy-10a,12a-dimethyl-, (1R,3aS,3bS,6aS,8S,9R,10aR,10bS,12aS)-
|
CAS | 82373-95-3
|
EINECS | 252-204-6 |
(22R,23R)-2A,3A,22,23-TETRAHYDROXY-24-ETHYL-BETA-HOMO-7-OXA-5A-CHOLESTAN-6-ONE - Physico-chemical Properties
Molecular Formula | C29H50O6
|
Molar Mass | 494.708 |
Density | 1.130±0.06 g/cm3(Predicted) |
Boling Point | 643.0±55.0 °C(Predicted) |
pKa | 14.27±0.70(Predicted) |
Storage Condition | 2-8℃ |
(22R,23R)-2A,3A,22,23-TETRAHYDROXY-24-ETHYL-BETA-HOMO-7-OXA-5A-CHOLESTAN-6-ONE - Introduction
(22R,23R)-2A,3A,22, is a compound with the chemical name (22R,23R)-2A,3A,22. The following is a description of the properties, uses, preparation and safety information of the compound:
Nature:
-Appearance:(22R,23R)-2A,3A,22, 3B are usually white to light yellow solids.
-Melting point: The melting point of the compound is about 82-87 degrees Celsius.
-Solubility:(22R,23R)-2A,3A,22, and calcium have good solubility in organic solvents such as chloroform, methanol, and dichloromethane.
Use:
- (22R,23R)-2A,3A,22, is a biologically active compound widely used in the field of biomedical research. It has important potential applications in cell biology, molecular biology and drug discovery.
-The compound can be used as a precursor compound for pharmaceutical research and used to synthesize other biologically active substances.
Method:
- (22R,23R)-2A,3A,22, and the synthesis method is more complicated, and generally requires a multi-step reaction in the synthesis process.
Safety Information:
-Because (22R,23R)-2A,3A,22, the specific use of the pill may be related to personal operation and laboratory conditions. In General, the introduction and use of the compound should follow the appropriate safety procedures, such as wearing appropriate personal protective equipment (such as gloves, eye protection, etc.).
-The specific toxicity and safety measures of the compound should be evaluated based on relevant safety data and in accordance with laboratory safety guidelines and regulatory requirements.
Last Update:2024-04-09 21:04:16